Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

NYSE:GCTS - New York Stock Exchange, Inc. - US36170N1072 - Common Stock - Currency: USD

1.45  +0.03 (+2.11%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GCTS. GCTS was compared to 109 industry peers in the Semiconductors & Semiconductor Equipment industry. GCTS may be in some trouble as it scores bad on both profitability and health. GCTS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GCTS has reported negative net income.
GCTS had a negative operating cash flow in the past year.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

GCTS's Return On Assets of -62.22% is on the low side compared to the rest of the industry. GCTS is outperformed by 88.07% of its industry peers.
Industry RankSector Rank
ROA -62.22%
ROE N/A
ROIC N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Gross Margin of GCTS (55.61%) is better than 77.98% of its industry peers.
The Profit Margin and Operating Margin are not available for GCTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GCTS has more shares outstanding
GCTS has a better debt/assets ratio than last year.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -45.64, we must say that GCTS is in the distress zone and has some risk of bankruptcy.
GCTS's Altman-Z score of -45.64 is on the low side compared to the rest of the industry. GCTS is outperformed by 89.91% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -45.64
ROIC/WACCN/A
WACC11.47%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

GCTS has a Current Ratio of 0.29. This is a bad value and indicates that GCTS is not financially healthy enough and could expect problems in meeting its short term obligations.
GCTS's Current ratio of 0.29 is on the low side compared to the rest of the industry. GCTS is outperformed by 95.41% of its industry peers.
GCTS has a Quick Ratio of 0.29. This is a bad value and indicates that GCTS is not financially healthy enough and could expect problems in meeting its short term obligations.
GCTS's Quick ratio of 0.24 is on the low side compared to the rest of the industry. GCTS is outperformed by 95.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.24
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.37% over the past year.
The Revenue has grown by 117.90% in the past year. This is a very strong growth!
EPS 1Y (TTM)5.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.54%
Revenue 1Y (TTM)117.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.39%

3.2 Future

Based on estimates for the next years, GCTS will show a very strong growth in Earnings Per Share. The EPS will grow by 42.60% on average per year.
The Revenue is expected to grow by 137.44% on average over the next years. This is a very strong growth
EPS Next Y16.67%
EPS Next 2Y59.16%
EPS Next 3Y42.6%
EPS Next 5YN/A
Revenue Next Year296.86%
Revenue Next 2Y227.68%
Revenue Next 3Y137.44%
Revenue Next 5YN/A

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GCTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GCTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

GCTS's earnings are expected to grow with 42.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.16%
EPS Next 3Y42.6%

More info and screens

0

5. Dividend

5.1 Amount

GCTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (4/17/2025, 8:24:17 PM)

1.45

+0.03 (+2.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)03-25 2025-03-25/amc
Earnings (Next)05-12 2025-05-12
Inst Owners6.53%
Inst Owner Change-1.14%
Ins Owners3.23%
Ins Owner Change-28.06%
Market Cap69.96M
Analysts82.86
Price Target5.1 (251.72%)
Short Float %2.97%
Short Ratio8.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.03%
Min EPS beat(2)1.96%
Max EPS beat(2)28.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)26.09%
Min Revenue beat(2)-13.85%
Max Revenue beat(2)66.03%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-37.5%
EPS NQ rev (1m)33.33%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)40.48%
EPS NY rev (3m)40.48%
Revenue NQ rev (1m)-57.31%
Revenue NQ rev (3m)-57.31%
Revenue NY rev (1m)-29.53%
Revenue NY rev (3m)-29.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.66
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.19
BVpS-1.23
TBVpS-1.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.61%
FCFM N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.91%
Cap/Sales 5.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.24
Altman-Z -45.64
F-Score3
WACC11.47%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.54%
EPS Next Y16.67%
EPS Next 2Y59.16%
EPS Next 3Y42.6%
EPS Next 5YN/A
Revenue 1Y (TTM)117.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.39%
Revenue Next Year296.86%
Revenue Next 2Y227.68%
Revenue Next 3Y137.44%
Revenue Next 5YN/A
EBIT growth 1Y-233.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.42%
EBIT Next 3Y50.09%
EBIT Next 5YN/A
FCF growth 1Y-243.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-250.71%
OCF growth 3YN/A
OCF growth 5YN/A